linkedin post 2018-04-17 04:38:07

Uncategorized
DATA ALONE IS INSUFFICIENT. “As genomics continues to expand and to mature by addressing nearly every imaginable biological question, it is increasingly clear that the primary analysis of the resulting data alone is no longer sufficient for extracting new biological insights.” https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-8-S2-S1 View in LinkedIn
Read More

linkedin post 2018-04-16 05:31:24

Uncategorized
MORE SOLOS. “Although genomics and systems biology have started to reshape a multitude of areas in biology, new subfields evolve with ever more specialization. Ironically, we suspect that systems biology and genomics are in fact contributing to a new era of specialization by creating entire new subfields such as developmental systems biology or pharmacogenomics.” https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-8-S2-S1 View in LinkedIn
Read More

linkedin post 2018-04-16 05:29:34

Uncategorized
TRANSCRIPTS ARE KEY. “As gene expression analysis continues the transition to high-throughput sequencing, transcripts rather than genes become the fundamental feature measured and will require the update of functional profiling methods to support transcript-level functional analyses of enrichment.” https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-8-S2-S1 View in LinkedIn
Read More

linkedin post 2018-04-16 05:28:11

Uncategorized
ARBITRARY FUNCTIONAL ASSIGNMENTS. “The assignment of genes to functions is still a largely unfinished task and the boundaries of pathway definitions are arbitrary: one database might include a set of genes within a specific signaling pathway while another would split this into two separate pathways.” https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-8-S2-S1 View in LinkedIn
Read More

linkedin post 2018-04-16 05:24:35

Uncategorized
FUNCTIONAL CHARACTERIZATION. “High throughput screening methods for protein-coding genes, or computational predictive approaches in the case of non-coding transcripts might help to speed up functional characterization but are still at their infancy and far from being generally applicable.” https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-8-S2-S1 View in LinkedIn
Read More

linkedin post 2018-04-16 05:22:41

Uncategorized
MICROBIOME STUDIES. “While we are accumulating large metagenomic datasets and cataloguing bacterial genomes that make up the different parts of the human microbiome in normal and diseased individuals, it is still very difficult to connect the presence or change in frequency of specific bacterial species with the associated phenotypes.” https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-8-S2-S1 View in LinkedIn
Read More

linkedin post 2018-04-16 05:21:02

Uncategorized
DRUGS AND GENES. “The new field of pharmacogenomics seeks to understand the interactions between drugs and individuals' genotype. For example about 14% of the population carry the *2 allele of the cytochrome P450 CYP2C19 that prevents the proper processing of the anti-clotting drug clopidogrel (Plavix) and thus renders the drug ineffective.” https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-8-S2-S1 View in LinkedIn
Read More